In vitro experiments indicate that the FTO inhibitor CS1 significantly inhibits cell proliferation and induces apoptosis in CRC-related cell lines and that it can downregulate the Akt/mTOR signaling pathway (187). This evidence concerns the gene FTO and colorectal carcinoma.